MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Fresenius Medical Care AG & Co KGaA

Отворен

24.34 1.21

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

23.99

Максимум

24.36

Ключови измерители

By Trading Economics

Приходи

-146M

119M

Продажби

325M

5.1B

P/E

Средно за сектора

22.615

57.333

EPS

0.455

Дивидентна доходност

2.73

Марж на печалбата

2.338

Служители

111,513

EBITDA

-565M

281M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+16.12% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

2.73%

2.63%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

224M

14B

Предишно отваряне

23.13

Предишно затваряне

24.34

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

Fresenius Medical Care AG & Co KGaA Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

21.03.2025 г., 08:19 ч. UTC

Пазарно говорене

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

25.02.2025 г., 10:27 ч. UTC

Пазарно говорене
Печалби

Fresenius Medical Care's U.S. Volume Growth Is Unlikely to Reassure Investors -- Market Talk

15.07.2024 г., 08:17 ч. UTC

Пазарно говорене

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

3.05.2024 г., 08:20 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Fresenius' Disposal of Part of Its Rehabilitation Business Seems Positive -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Fresenius Medical Care AG & Co KGaA Прогноза

Ценова цел

By TipRanks

16.12% нагоре

12-месечна прогноза

Среден 27.45 USD  16.12%

Висок 28.9 USD

Нисък 26 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Fresenius Medical Care AG & Co KGaA през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

5 ratings

2

Купи

3

Задържане

0

Продай

Техническа оценка

By Trading Central

23.5 / 23.6799Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

Very Strong Bearish Evidence

Дългосрочен план

Weak Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Fresenius Medical Care AG & Co KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.